Search clinical trials for: somatropin (rDNA)

Total 1404 results

Eli Lilly and Company

Completed

Somatropin Treatment in Patients With SHOX Deficiency and Turner Syndrome

Failure to Thrive

United States
Ipsen

Completed

Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq (OPTIMA)

Renal Insufficiency, Chronic | Pituitary Diseases | Dwarfism | Turner Syndrome

France, Germany, Finland, Spain, Belgium, Czechia, Denmark, Greece, Italy, Romania, Russian Federation, Slovakia, Ukraine, United Kingdom
Eli Lilly and Company

Completed

Observational Study of Somatropin Treatment in Children (GeNeSIS)

Growth Hormone (GH) Deficiency | Short Stature Homeobox Containing Gene (SHOX) Deficiency | SHOX Deficiency-related Disorder | Non-GH-deficient Growth Disorders
OPKO Health, Inc.

Active, not recruiting

Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

Pediatric Growth Hormone Deficiency

Israel, United States, India, Korea, Republic of, Australia, Taiwan, Spain, Argentina, Belarus, Bulgaria, Canada, Colombia, Georgia, Greece, Mexico, New Zealand, Poland, Russian Federation, Ukraine, United Kingdom
Eli Lilly and Company

Completed

A Prospective Observational Study of Effect of Somatropin on Growth Hormone Deficient Adults (HypoCCS)

Hypopituitarism | Pituitary Insufficiency | Growth Hormone Deficiency, Adult
Eli Lilly and Company

Completed

Amendment (g) Unblinded Extension Phase of Somatropin in Patients With Idiopathic Short Stature

Growth Disorder

United States
Ipsen

Terminated

rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency

Insulin-like Growth Factor-1 Deficiency

United States
Genentech, Inc.

Terminated

A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device

Growth Hormone Deficiency

United States
Ipsen

Withdrawn

Predictive Value of the Insulin-like Growth Factor-1 (IGF-1) Generation Test for the Growth Response to Growth Hormone Treatment (PRED-IGF)

Idiopathic Short Stature
Genentech, Inc.

Completed

A Study to Evaluate Nutropin AQ for the Treatment of Growth Restriction in Children With Cystic Fibrosis

Cystic Fibrosis
Sakakibara Heart Institute
Japanese Foundation for Cancer Research

Completed

Pathogenic Mechanisms of Cancer and Cardiovascular Diseases

Cardiovascular Diseases | Cancer | Pathogenesis

Japan
Visen Pharmaceuticals (Shanghai) Co., Ltd.
Ascendis Pharma A/S

Unknown

Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Chinese Pediatric Growth Hormone Deficiency

Endocrine System Diseases | Pituitary Diseases | Growth Hormone Deficiency | Hormones | Pituitary Disease, Anterior

China
Lundquist Institute for Biomedical Innovation at...

Terminated

Clinical Trial of Growth Hormone in MPS I, II, and VI

Mucopolysaccharidosis I | Mucopolysaccharidosis II | Mucopolysaccharidosis VI

United States
Nationwide Children's Hospital
Pfizer

Terminated

Growth Hormone in Children With Juvenile Rheumatoid Arthritis (JRA) and With Crohn's Disease

Crohn Disease | Arthritis, Juvenile Rheumatoid

United States
Xiamen Amoytop Biotech Co., Ltd.
Peking Union Medical College Hospital

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Pegylated-Somatropin in Healthy Volunteers (Somatropin)

Healthy

China
Pfizer

Active, not recruiting

Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS

Prader-Willi Syndrome

Japan
Center for Neurological Studies
Novo Nordisk A/S

Recruiting

Growth Hormone Replacement Therapy for Retried Professional Football Players

TBI (Traumatic Brain Injury) | Growth Hormone Deficiency | Hypopituitarism | Sport Injury | Concussion, Brain | Anterior Pituitary Hyposecretion Syndrome

United States
Pfizer

Completed

Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm

Growth Hormone Deficiency

France
Novo Nordisk A/S

Completed

Genetic Testing of Noonan Subjects Previously Treated With Norditropin®. An Extension to Trial GHNOO-1658

Noonan Syndrome | Genetic Disorder

Sweden
Novo Nordisk A/S

Completed

Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature Due to Noonan Syndrome)

Noonan Syndrome | Genetic Disorder

Japan
LG Chem

Completed

6x3 Crossover, Bioavailability, Safety and Tolerability Among Different Eutropin Formulations in Healthy Volunteers

Bioavailability, Safety and Tolerability Among Different Eutropin Formulations in Healthy Volunteers

Korea, Republic of
Novo Nordisk A/S

Completed

Observational Study of the Safety and Efficacy of Norditropin® in Patients With SGA (Small for Gestational Age) Short Stature That Are Still Growing

Foetal Growth Problem | Small for Gestational Age

Japan
Novo Nordisk A/S

Completed

A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin

Achondroplasia | Genetic Disorder

Japan
Novo Nordisk A/S

Completed

Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan Syndrome

Noonan Syndrome | Genetic Disorder

Sweden
Novo Nordisk A/S

Withdrawn

Bioequivalence of Two Products (Norditropin® Versus Nutropin AQ®) in Healthy Adult Volunteers

Healthy | Growth Disorder
GeneScience Pharmaceuticals Co., Ltd.
The First Affiliated Hospital with Nanjing Medical University; Tongji Hospital and other collaborators

Active, not recruiting

A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature

Dwarfism

China
Novo Nordisk A/S

Completed

Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome

Noonan Syndrome | Genetic Disorder

Japan
Novo Nordisk A/S

Completed

Safety and Efficacy of Long-term Somatropin Treatment in Adults (NordiWIN)

Growth Hormone Disorder | Adult Growth Hormone Deficiency

Germany
Massachusetts General Hospital

Unknown

Study to Examine Insulin Resistance During Growth Hormone Treatment for Short Stature Due to Low Birthweight

Fetal Growth Retardation

United States
Novo Nordisk A/S

Completed

French National Registry of Children Born Small for Gestational Age Treated With Somatropin

Small for Gestational Age | Growth Disorder

France
Novo Nordisk A/S

Completed

Observational Prospective Study on Patients Treated With Norditropin®

Chronic Kidney Disease | Turner Syndrome | Noonan Syndrome | Chronic Renal Insufficiency | Growth Hormone Disorder | Growth Hormone Deficiency in Children | Adult Growth Hormone Deficiency | Genetic Disorder | Foetal Growth Problem | Small for Gestational Age

Israel, Saudi Arabia, Spain, Argentina, Russian Federation, Germany, Netherlands, Italy, Belgium, United Kingdom, Slovenia, Ireland, Sweden, Denmark, Hungary, Finland, Norway, France, Czechia, Lithuania, Luxembourg, Serbia, Switzerland
Novo Nordisk A/S

Completed

Growth Response in Girls With Turner Syndrome

Turner Syndrome | Genetic Disorder

France
Novo Nordisk A/S

Completed

Use of Somatropin in Turner Syndrome

Turner Syndrome | Genetic Disorder

United Kingdom
Novo Nordisk A/S

Completed

Special Survey for Long Term Application

Achondroplasia | Genetic Disorder

Japan
Novo Nordisk A/S

Completed

Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers

Healthy | Prader-Willi Syndrome | Genetic Disorder | Growth Disorder | Idiopathic Short Stature

United States
Novo Nordisk A/S

Completed

Safety and Efficacy of Long-term Somatropin Treatment in Children (GrowthWIN II)

Turner Syndrome | Growth Hormone Disorder | Growth Hormone Deficiency in Children | Genetic Disorder | Foetal Growth Problem | Small for Gestational Age | Growth Disorder | Idiopathic Short Stature

Germany
Pfizer

Completed

Growth Retardation In Children With Special Pathological Conditions Or Disease

Endocrine System Diseases

France
Azidus Brasil

Unknown

Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Somatropin Produced by Laboratory Blausiegel Indústria e Comércio Ltda., Compared to Saizen® From Laboratory Merck Serono S.A.

Growth Retardation | GH Deficiency (GHD)

Brazil
University of Nebraska
Eli Lilly and Company

Terminated

Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS)

Short Bowel Syndrome

United States
Massachusetts General Hospital

Terminated

Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short Stature

Turner Syndrome | Idiopathic Short Stature

United States
Pfizer

Completed

Special Investigation Of Genotropin Long Follow-Up For Patients With A Small For Gestational Age "Scoped for Japanese"

Small for Gestational Age (SGA)
Novo Nordisk A/S

Terminated

The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis (OPPORTUNITY)

Chronic Kidney Disease | End-Stage Renal Disease

France, United States, Spain, United Kingdom, Canada, Denmark, Germany, Sweden, Argentina, India, Israel, Russian Federation, Hungary, Turkey, Italy, Poland, South Africa, China, Brazil, Portugal, Puerto Rico
The University of Texas Health Science Center at...

Not yet recruiting

Genetic Investigation of Cancer Predisposition

Cancer | Genetic Predisposition

United States
Ascendis Pharma Endocrinology Division A/S

Recruiting

A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome

Turner Syndrome

United States
Novo Nordisk A/S

Completed

A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of Somatropin

Healthy | Growth Hormone Disorder | Adult Growth Hormone Deficiency

United States
GeneScience Pharmaceuticals Co., Ltd.
Children's Hospital of Fudan University; The First Hospital of Jilin University and other collaborators

Unknown

Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature

Small for Gestational Age Infant

China
HanAll BioPharma Co., Ltd.

Completed

Safety, Pharmacokinetics and Pharmacodynamics Study of HL-032 in Healthy Male Volunteers (HL-032)

Growth Hormone Deficiency

Korea, Republic of
Pfizer

Completed

Study Aimed At Improving Height With Genotonorm In Children Born Little And/Or Light With Growth Retardation At The Age

Fetal Growth Retardation

France
Sandoz

Completed

Safety and Efficacy of Omnitrope® (rhGH) in Short Children Born Small for Gestational Age (SGA)

Small for Gestational Age

Belgium, Czechia, Georgia, Hungary, Poland, Romania, Germany
Novo Nordisk A/S

Enrolling by invitation

French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome

Noonan Syndrome

France

Search clinical trials for: somatropin (rDNA)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations